Novelion Therapeutics Inc., of Vancouver, British Columbia, said subsidiary Aegerion Pharmaceuticals Inc. entered a secured financing facility with affiliates of Sarissa Capital Management and Broadfin Capital providing for a $20 million term loan to Aegerion, which has been fully drawn.